To address clinical unmet needs and support
better human health, become one of the top
tier pharmaceutical companies in China.
Better Generics
Superior Innovatives
Agility
Innovation
Be Reslistic
Collaboration
Ownership
R & D System
Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.
R & D Platform
Preclinical Research Platform
Pharmaceutical Research Platform
Clinical Research Platform
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
R & D Achievements
Over 40 clinical trial permissions approved by CFDA
Over 20 drugs were applied for the
manufacturing licenses with 10+ approved Over 10 APIs passed review
R & D System
Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.
More
R & D Platform
Preclinical Research Platform <br> Pharmaceutical Research Platform<br> Clinical Research Platform
More
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
More
R & D Achievements
Over 40 clinical trial permissions approved by CFDA<br> Over 20 drugs were applied for the<br> manufacturing licenses with 10+ approved Over 10 APIs passed review
More
2022年11月
04
上海匯倫湖北制藥有限公司原料藥生產基地項目弱電工程投標邀請書
湖北匯倫的原料藥生產基地項目目前正在籌建中，現對原料藥生產基地項目弱電工程進行邀標，施工方選擇方式為多家議標擇優合作，歡迎有履約能力的單位按本邀標書的有關要求前來投標，該投標書內容將與合同具有同等法律效力。
2022年09月
26
上海匯倫江蘇藥業有限公司原料藥生產項目電梯設備議標邀請書
現擬招該項目電梯設備采購，歡迎有履約能力的單位按本邀標書的有關要求前來投標，該投標書內容將與合同具有同等法律效力。
2022年09月
21
上海匯倫湖北制藥有限公司原料藥生產基地項目室外圍墻工程投標邀請書
上海匯倫湖北制藥有限公司（簡稱“湖北匯倫”）是上海匯倫醫藥股份有限公司的全資子公司。湖北匯倫的原料藥生產基地項目目前正在籌建中，現對原料藥生產基地項目室外圍墻工程進行邀標，施工方選擇方式為多家議標擇優合作，歡迎有履約能力的單位按本邀標書的有關要求前來投標，該投標書內容將與合同具有同等法律效力。
